Funding agencies: Michael J. Fox Foundation (MJFF); Northwestern Memorial Foundation Dixon Priority award.
Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
Article first published online: 30 SEP 2013
© 2013 Movement Disorder Society
Volume 28, Issue 13, pages 1823–1831, November 2013
How to Cite
Parkinson Study Group (2013), Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). Mov. Disord., 28: 1823–1831. doi: 10.1002/mds.25639
Relevant conflicts of interest/financial disclosures: J.D. Surmeier has a pending use patent for the use of dihydropyridine compounds in Parkinson's disease. The rest of the authors have nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
Members of the Parkinson Study Group are listed in the Appendix.
- Issue published online: 13 NOV 2013
- Article first published online: 30 SEP 2013
- Manuscript Accepted: 4 JUN 2013
- Manuscript Revised: 30 MAY 2013
- Manuscript Received: 17 APR 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.